genebiotherapeutics.com | Gene Biotherapeutics | Cardiac Angiogenic Gene Therapy Finding New Ways To

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# Default robots file version:2 User-agent: * Disallow: /calendar/action* Disallow: /events/action* Allow: /.css Allow: /.js Disallow: /*? Crawl-delay:

Meta Tags

Title	Gene Biotherapeutics \| Cardiac Angiogenic Gene Therapy Finding New Ways To
Description	Cardiac Angiogenic Gene Therapy: Finding New Ways to Gene Biotherapeutics is a publicly-traded, clinical development-stage biotechnology company engaged in the clinical advancement and commercialization of DNA-based biotherapeutics, primarily for the treatment of cardiovascular
Keywords	N/A

Server Information

WebSite	genebiotherapeutics.com
Host IP	151.101.130.159
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

genebiotherapeutics.com Valuation

US$1,666,817

Last updated: 2023-05-11 23:34:53

genebiotherapeutics.com has Semrush global rank of 6,350,012. genebiotherapeutics.com has an estimated worth of US$ 1,666,817, based on its estimated Ads revenue. genebiotherapeutics.com receives approximately 192,325 unique visitors each day. Its web server is located in United States, with IP address 151.101.130.159. According to SiteAdvisor, genebiotherapeutics.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,666,817
Daily Ads Revenue	US$1,539
Monthly Ads Revenue	US$46,158
Yearly Ads Revenue	US$553,896
Daily Unique Visitors	12,822
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
genebiotherapeutics.com. 1799	A	genebiotherapeutics.com. 1799	IP: 151.101.130.159
genebiotherapeutics.com. 21600	NS	genebiotherapeutics.com. 21600	NS Record: ns1.bdm.microsoftonline.com.
genebiotherapeutics.com. 21600	NS	genebiotherapeutics.com. 21600	NS Record: ns2.bdm.microsoftonline.com.
genebiotherapeutics.com. 21600	NS	genebiotherapeutics.com. 21600	NS Record: ns3.bdm.microsoftonline.com.
genebiotherapeutics.com. 21600	NS	genebiotherapeutics.com. 21600	NS Record: ns4.bdm.microsoftonline.com.
genebiotherapeutics.com. 3600	MX	genebiotherapeutics.com. 3600	MX Record: 0 genebiotherapeutics-com.mail.protection.outlook.com.
genebiotherapeutics.com. 3600	TXT	genebiotherapeutics.com. 3600	TXT Record: mscid=p54w4o1CNbFgkcOyzrRUCm43Tg/OyY7mLwsm2VZEyv1k/qB1hkNiBG/0iOvIimI/KlbZdYW7idhOZfLde2OTCA==
genebiotherapeutics.com. 3600	TXT	genebiotherapeutics.com. 3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-11 23:34:53

Skip to primary navigation Gene Biotherapeutics Cardiac Angiogenic Gene Therapy Finding New Ways To Heal Clinical Trial Science Therapeutics Investors About Press Contact Main Content Cardiac Angiogenic Gene Therapy: Finding New Ways to Heal Our Science Gene Biotherapeutics is a publicly-traded, clinical development-stage biotechnology company engaged in the clinical advancement and commercialization of DNA-based biotherapeutics, primarily for the treatment of cardiovascular disease. Clinical Trial The Phase 3 “AFFIRM” clinical study evaluates Gene Biotherapeutics’ lead product candidate, Generx [Ad5FGF-4], as a one-time administration for the treatment of refractory angina due to late-stage coronary artery disease. Clinical Trial Our Science Gene Biotherapeutics’ angiogenic gene therapy is designed to improve cardiac perfusion (blood flow) and to increase the supply of oxygenated blood by promoting the growth of microvasculature in ischemic cardiac tissue. Our Science Generx Product

HTTP Headers

HTTP/1.1 301 Moved Permanently
Content-Type: text/html
Location: https://genebiotherapeutics.com/
X-XSS-Protection: 1
X-Content-Type-Options: nosniff
Referrer-Policy: no-referrer-when-downgrade
X-FW-Server: Flywheel/5.1.0
X-FW-Hash: 7zmew38y21
X-FW-Version: 5.0.0
Server: Flywheel/5.1.0
Content-Length: 162
Accept-Ranges: bytes
Date: Fri, 19 Nov 2021 08:31:24 GMT
Connection: keep-alive
X-Served-By: cache-chi21170-CHI
X-Cache: MISS
X-Cache-Hits: 0
X-Timer: S1637310684.955362,VS0,VE101
Vary: Authorization
X-FW-Serve: TRUE
X-FW-Static: NO
X-FW-Type: FLYWHEEL_BOT

HTTP/2 200 
content-type: text/html; charset=UTF-8
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-xss-protection: 1
x-content-type-options: nosniff
referrer-policy: no-referrer-when-downgrade
x-fw-server: Flywheel/5.1.0
x-fw-dynamic: TRUE
x-fw-hash: 7zmew38y21
x-fw-version: 5.0.0
server: Flywheel/5.1.0
x-cacheable: YES
fastly-restarts: 1
accept-ranges: bytes
date: Fri, 19 Nov 2021 08:31:24 GMT
x-served-by: cache-chi21178-CHI
x-cache: MISS
x-cache-hits: 0
x-timer: S1637310684.238764,VS0,VE569
vary: Accept-Encoding, Accept-Encoding
x-fw-serve: TRUE
x-fw-static: NO
x-fw-type: FLYWHEEL_BOT
content-length: 43083

genebiotherapeutics.com Whois Information

Domain Name: GENEBIOTHERAPEUTICS.COM
Registry Domain ID: 2185792254_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2020-10-31T03:25:46Z
Creation Date: 2017-11-10T19:50:30Z
Registry Expiry Date: 2023-11-10T19:50:30Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.BDM.MICROSOFTONLINE.COM
Name Server: NS2.BDM.MICROSOFTONLINE.COM
Name Server: NS3.BDM.MICROSOFTONLINE.COM
Name Server: NS4.BDM.MICROSOFTONLINE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-11-19T07:30:24Z <<<

genebiotherapeutics.com valuation and analysis